AgaMatrix blood glucose meters and strips by Amazon could make ordering diabetes supplies more convenient and cheaper

The latest updates on time-in-range goals for people with all types of diabetes, and insights linking FreeStyle Libre scanning frequency to outcomes.

Resource at DANAtech.org for AADE members with current diabetes device information, news, education, and app reviews; supported by the Helmsley Charitable Trust

FDA updates Invokana label – the type 2 diabetes therapy now improves heart health in type 2’s with established heart disease in addition to glucose lowering

MiniMed 780G to add automated correction boluses and Bluetooth, aims to launch by April 2020; Guardian Connect users can now use IQcast on Apple iPhones

Big focus on heart health outcome trials with PIONEER 6 and CAROLINA in the spotlight; plus promising CGM data in adolescents with type 1 diabetes

To commemorate World Obesity Day, we are raising attention on terribly stigmatizing language around obesity and weight

A new guidance document from the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) calls for more patient-centered care and...

The latest on the first automated insulin delivery system with automatic boluses and no-fingersticks CGM. The pivotal trial has been temporarily paused and will resume...

Recently announced results from the REWIND and EMPRISE studies show heart protective effects of GLP1-agonist Trulicity and SGLT-2 inhibitor Jardiance in people with and...

Sanofi covers all insulins under this program, including Toujeo, Lantus, Admelog, Apidra.

By Peter Rentzepis and Kelly Close Passing of Dr. Lois Jovanovic, the leading figure in pregnancy and diabetes, brings sorrow to many; friends and colleagues share...

FlowSmart infusion set officially discontinued. On the plus side, BD plans to launch a tubeless type 2 diabetes insulin patch pump starting in late 2019.

A preview of the most exciting conference updates on diabetes drugs, devices, and more; stay tuned!

New guidelines by the US Department of Health and Human Services emphasize the benefit of ANY increased physical activity

Amarin’s Vascepa, an omega-3 fatty acid, is shown to lower risk of heart attack, stroke, and heart-related death for adults with high risk for heart disease with...

The diaTribe team was on the ground at the 2019 ADA 79th Scientific Sessions to share several of the greatest highlights from the conference!

Eli Lilly to donate 200,000 insulin pens and provide $2 million for diabetes education to 200 free clinics across the United States by 2022

A new premixed, liquid glucagon coming in October in a prefilled syringe and in 2020 as an auto-injector. The second stable glucagon approved this year

Farxiga’s heart health benefits were the same in people with and without diabetes, as well as across a spectrum of baseline A1C levels